Atlas Trials

the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

Clinical trial NCT04521400 · UNKNOWN

Trial details

NCT number
NCT04521400
Sponsor
Shahid Beheshti University of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-08-20
Primary completion
2020-09-04
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.